Hemogenyx Pharmaceuticals Regulatory News (HEMO)

7 December 2015

SILVER FALCON PLC

("Silver Falcon" or the "Company")

Statement regarding media speculation and share price movement

Silver Falcon PLC (LSE: SILF), the Main Board listed special purpose acquisition company set up to acquire businesses in the FinTech space, notes recent press speculation and movements in its share price.

The Company notes that a number of material pieces of information in recent press speculation are factually incorrect and should not be relied upon.

Whilst the Company has had initial discussions with a possible target concerning a possible transaction, all such discussions are at a preliminary stage. No exclusivity agreement or other binding, or non-binding agreements have been entered into with any party, and there is no certainty that any such agreements will be made. A further announcement will be made in due course.

For further information please contact:

Camarco Tel: +44 (0) 20 3757 4980

Jennifer Renwick / Billy Clegg / Zoё Moulton